(Q27851964)

13 November 2016

title

Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells (English)

1 reference

IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer

PubMed

PubMed publication ID

13 November 2016

0 references

1 reference

1 reference

Zhen-Yu Ding

0 references

Gui-Hong Liu

series ordinal

0 references

Birgit Olsson

series ordinal

0 references

Xiao-Feng Sun

series ordinal

0 references

publication date

April 2013

0 references

0 references

0 references

0 references

683-93

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

KIAP, a novel member of the inhibitor of apoptosis protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

Livin, a novel inhibitor of apoptosis protein family member

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

IAP proteins: sticking it to Smac

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

Livin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

Colorectal cancer incidence trends in the United States and United kingdom: evidence of right- to left-sided biological gradients with implications for screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

Expression of IAP family proteins in colon cancers from patients with different age groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

Livin gene plays a role in drug resistance of colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

DHA alters expression of target proteins of cancer therapy in chemotherapy resistant SW620 colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

Apoptosis: controlled demolition at the cellular level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

Subcellular localization determines the delicate balance between the anti- and pro-apoptotic activity of Livin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

VEGF stimulation enhances Livin protein synthesis through mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

Ras, PI(3)K and mTOR signalling controls tumour cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

mTOR: from growth signal integration to cancer, diabetes and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0596-8

Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin results in cytostasis and apoptosis.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23188704

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prognostic value of Survivin and Livin in nasopharyngeal carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23188704